Kaohsiung, Taiwan

Chau-Zen Wang


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Chau-Zen Wang

Introduction

Chau-Zen Wang is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of bone-related diseases. With a total of 2 patents, his work focuses on innovative methods to address osteoporosis and joint diseases.

Latest Patents

Wang's latest patents include groundbreaking methods for treating or alleviating bone-loss related diseases. One of his inventions involves administering a nucleic acid encoding a discoidin domain receptor 1 (DDR1) protein to treat osteoporosis. This method identifies subjects with osteoporosis and administers an effective amount of a composition that increases the level of DDR1 protein in the subject. Another patent focuses on treating joint diseases by using an inhibitor of DDR1. This invention relates to the preparation of a medicament for preventing or treating joint diseases and abnormalities of endochondral ossification-related conditions.

Career Highlights

Chau-Zen Wang is affiliated with Kaohsiung Medical University, where he conducts research and develops innovative medical solutions. His work has garnered attention for its potential impact on improving the quality of life for individuals suffering from bone and joint conditions.

Collaborations

Wang collaborates with esteemed colleagues, including Chung-Hwan Chen and Liang-Yin Chou, to further advance research in his field. Their combined expertise contributes to the development of effective treatments and therapies.

Conclusion

Chau-Zen Wang's contributions to medical science through his patents demonstrate his commitment to innovation in treating bone and joint diseases. His work continues to pave the way for advancements in healthcare and patient treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…